MDT · Targeted therapy · Rare & complex tumours
Targeted & Precision Oncology
For GEP-NETs, GIST, pheochromocytoma and bladder cancer — end-to-end multidisciplinary care from precision diagnosis to post-treatment management.
Nuclear OncologyGEP-NETs — 177Lu-PRRT Targeted Radionuclide Therapy
Full closed-loop service: 68Ga-PET/CT somatostatin receptor imaging, dosimetry calculation, shielded ward treatment and follow-up PRRT cycles. Available to patients from countries with no access to PRRT.
Price
Est. from $9,800
Stay
14–21 days per cycle
Check treatment eligibility →
Gastrointestinal OncologyGIST — NGS Profiling + TKI Targeted Therapy
Next-generation sequencing identifies KIT / PDGFRA / SDH mutation status to guide imatinib, sunitinib or ripretinib sequencing. Domestic generic TKIs reduce annual drug cost by 75% vs. imported brands.
Price
Est. from $6,500
Stay
Ongoing (annual management)
Check treatment eligibility →
Endocrine OncologyPheochromocytoma — MDT + NanoKnife / Cryoablation
High-risk adrenal tumour resection with pre-operative alpha-blockade protocol. NanoKnife (IRE) and cryoablation available for lesions deemed unresectable by conventional surgery.
Price
Est. from $12,000
Stay
14–18 days
Check treatment eligibility →
Urological OncologyBladder Cancer — Total Laparoscopic Radical Cystectomy
Minimally invasive radical cystectomy with orthotopic neobladder or ileal conduit urinary diversion. High-volume centres perform 200+ bladder cancer surgeries annually.
Price
Est. from $11,000
Stay
14–21 days
Check treatment eligibility →
Free second opinion · Response within 24 hours
Ready to explore
your options?
Submit your medical records and a senior oncology coordinator will assess your case within 24 hours — no obligation, completely confidential.
- Free case assessment
- Strictly confidential
- No upfront fees
- Senior oncologist review